Sign Up Today and Learn More About Syzygy Plasmonics Stock
Invest in or calculate the value of your shares in Syzygy Plasmonics or other pre-IPO companies through EquityZen, part of Morgan Stanley.
Syzygy Plasmonics Stock (SYPL)
Syzygy Plasmonics is a developer of a photocatalytic reactor designed for fuel cell vehicles and small-scale industrial applications.
About Syzygy Plasmonics Stock
Founded
2017
Headquarters
Houston, TX, US
Industries
Software, Artificial Intelligence, Data and Analytics
Syzygy Plasmonics Press Mentions
Stay in the know about the latest news on Syzygy Plasmonics
Syzygy Plasmonics and IFC Partner to Advance Sustainable Aviation Fuel Projects Across Latin America
prnewswire • Aug 18, 2026
Tüpraş Ventures’tan üç yeni yatırım: Syzygy Plasmonics, Aqualung Carbon Capture ve Via Separations
egirisim • Jun 18, 2026
Syzygy Plasmonics Signs Capacity Reservation Agreement with World Fuel for Future SAF Production
prnewswire • Jun 09, 2026
US Innovator Crosses The Bridge From Powdered Milk To SAF
cleantechnica • May 11, 2026
Syzygy Plasmonics Secures MOU with Geo Bio Gas&Carbon to Transform Brazil's Biogas into Sustainable Aviation Fuel
prnewswire • Mar 04, 2026
Syzygy Plasmonics Management
Leadership team at Syzygy Plasmonics
Director Governance Risk and Assurance
Thomas Henry
Co-Founder and Chief Technology Officer
Suman Khatiwada
Join now and verify your accreditation status to gain access to:
- Syzygy Plasmonics Current Valuation
- Syzygy Plasmonics Stock Price
- Syzygy Plasmonics Management
- Available deals in Syzygy Plasmonics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Syzygy Plasmonics Cap Table and Funding History by Share Class and Liquidity Preferences
- Syzygy Plasmonics Revenue and Financials
- Syzygy Plasmonics Highlights
- Syzygy Plasmonics Business Model
- Syzygy Plasmonics Risk Factors
- Syzygy Plasmonics Research Report from SACRA Research
Trading Syzygy Plasmonics Stock
How to invest in Syzygy Plasmonics stock?
Accredited investors can buy pre-IPO stock in companies like Syzygy Plasmonics through EquityZen funds. These investments are made available by existing Syzygy Plasmonics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Syzygy Plasmonics stock?
Shareholders can sell their Syzygy Plasmonics stock through EquityZen's private company marketplace. EquityZen's network includes over 480K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 56K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
